374 filings
Page 3 of 19
144
Athos KG
28 Jun 23
Notice of proposed sale of securities
5:20pm
6-K
BNTX
BioNTech SE
26 Jun 23
Current report (foreign)
5:26pm
6-K
BNTX
BioNTech SE
23 Jun 23
Current report (foreign)
4:41pm
6-K
BNTX
BioNTech SE
2 Jun 23
BioNTech and OncoC4 Present Positive Phase 1/2 Data for Antibody Candidate BNT316/ONC-392 in Hard-to-Treat NSCLC at ASCO
8:51am
6-K
BNTX
BioNTech SE
2 Jun 23
Current report (foreign)
8:48am
6-K
BNTX
BioNTech SE
26 May 23
Pfizer and BioNTech Provide Update on COVID-19 Vaccine Supply Agreement with the European Commission
7:43am
6-K
BNTX
BioNTech SE
25 May 23
Changes in the Supervisory Board of BioNTech SE and Voting Results from the Annual General Meeting 2023
4:06pm
6-K
BNTX
BioNTech SE
8 May 23
Current report (foreign)
9:22am
6-K
BNTX
BioNTech SE
8 May 23
Current report (foreign)
6:56am
6-K
BNTX
BioNTech SE
8 May 23
BioNTech Announces First Quarter 2023 Financial Results and Corporate Update
6:53am
6-K
BNTX
BioNTech SE
13 Apr 23
Invitation to the Annual General Meeting 2023
4:25pm
6-K
BNTX
BioNTech SE
3 Apr 23
Current report (foreign)
8:07am
6-K
BNTX
BioNTech SE
28 Mar 23
BioNTech Announces New ADS Repurchase Program
6:59am
20-F
2022 FY
BNTX
BioNTech SE
Annual report (foreign)
27 Mar 23
7:00am
6-K
BNTX
BioNTech SE
27 Mar 23
BioNTech Announces Fourth Quarter and Full Year 2022 Financial Results and Corporate Update
6:49am
6-K
BNTX
BioNTech SE
20 Mar 23
BioNTech and OncoC4 Announce Strategic Collaboration to Co-Develop and Commercialize Novel Checkpoint Antibody in Multiple Solid Tumor Indications
8:00am
6-K
BNTX
BioNTech SE
14 Mar 23
Pfizer and BioNTech Receive U.S. Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Booster
6:12pm
6-K
BNTX
BioNTech SE
1 Mar 23
Current report (foreign)
9:01am
6-K
BNTX
BioNTech SE
24 Feb 23
Current report (foreign)
8:58am
SC 13G/A
BNTX
BioNTech SE
22 Feb 23
BioNTech SE / Medine GmbH ownership change
12:00am